A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses
Sign Up to like & getrecommendations! Published in 2025 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2424889122
Abstract: Significance Anti-influenza therapeutics remain essential for the control of influenza infections, which may require hospitalization for the most severe cases. Hemagglutinin (HA) and neuraminidase (NA), the two membrane glycoproteins of the influenza virus, play crucial… read more here.
Keywords: monoclonal anti; hemagglutinin stem; antibody; stem ... See more keywords